2025HPTN 084-01StudiesSafety, tolerability, and acceptability of long-acting injectable cabotegravir for HIV prevention in cisgender female adolescents (HPTN 084-01): a single-arm, open-label, phase 2b trialSafety, tolerability, and acceptability of long-acting injectable cabotegravir for HIV prevention in cisgender female adolescents (HPTN 084-01)_ a single-arm, open-label, phase 2b trial - PIIS2352301824003102
